Executive Director
Bristol-Myers Squibb Company
Skillman, New Jersey
Otilia Koo, Ph.D. is currently Executive Director, Global Product Development and Supply (GPS) at Bristol-Myers Squibb (BMS). Her past experience in BMS included leading CMC teams in the development of small molecules and biologics for Immuno-Oncology and late stage formulation development at BMS and Head of Strategy & Business Operations of Cell Therapy Development and Operations. Otilia Koo is also a member of the 2020-2025 USP Council of Experts and Chair of the Expert Committee for Complex Excipient Monographs, and had been a USP Expert Committee member in 2015-2020. Her research interests and publications are in excipients characterization, the role of excipients in formulation development and processes and targeted lipid-based drug delivery systems. Otilia Koo was lead guest editor of themed issues in AAPS Journal and AAPS Pharm SciTech. Otilia Koo is also the sole editor for the book, "Pharmaceutical Excipients: Overview, Functionality, and Applications in Research and Industry" published in 2017. Otilia Koo received her Ph.D. in Pharmaceutics from the University of Illinois at Chicago, and Masters/Bachelor from the National University of Singapore. She also was an adjunct assistant professor at University of Illinois at Chicago from 2009-2019. She is first inventor in over 4 formulation patent applications.
Disclosure information not submitted.
Wednesday, October 19, 2022
10:30 AM – 11:30 AM ET